Healthtech,raised properly
Digital health and care technology, raised on adoption evidence, procurement reality and a credible route to contracted revenue.
What is different about raising in healthtech
NHS and private procurement cycles are the single biggest driver of the revenue model. Investors test whether you have modelled them honestly.
Clinical safety, information governance and any medical device classification are diligence items from day one.
Pilots are not revenue. Committees look for conversion from pilot to contract.
The engine behind the raise
Capital types we most often work across here: Venture capital, Growth equity, Strategic and corporate.
- Adoption and procurement narrative: pipeline, cycle length, pilot to contract conversion
- Clinical safety, DTAC and information governance documentation indexed in the data room
- Revenue model stress-tested against real procurement timelines
- Investor audience across healthtech specialists, family offices and strategic buyers
- Investor operations and reporting from first outreach to close
The questions capital will ask
If you cannot answer these with evidence in the data room, the process stalls at week two.
- How many pilots, and what proportion converted to paid contracts?
- What is the contracted annual recurring revenue, as opposed to pipeline?
- What is your device classification and clinical safety position?
- Who owns the data, and what is the information governance position?
We work across private markets
Fintech
Payments, lending, wealth infrastructure and embedded finance, raised with materials that survive a diligence team who already knows the sector.
View sectorDeeptech
Hard science, long horizons and technical risk, presented so a generalist committee can underwrite what a specialist already understands.
View sectorTechnology and software
SaaS, marketplaces and platforms, raised on metrics that reconcile to the accounts rather than to a slide.
View sectorLife sciences
Clinical, regulatory and reimbursement risk explained in one sequence a committee can underwrite.
View sectorBiotech
Platform or asset, preclinical or clinical, the raise gets built around what the next milestone proves and what it costs.
View sectorEngineering and industrials
Manufacturing, advanced engineering and industrial businesses, raised on order book, capacity and the capex plan behind them.
View sectorCleantech and energy transition
Where technology risk meets project risk, raised with the structure, offtake and permitting position resolved before outreach begins.
View sectorInfrastructure projects
Shovel-ready or nearly there, raised on planning, permits, offtake and a contracting structure that stands up to lender diligence.
View sectorReal estate
Development and income strategies, raised on site control, planning status, debt position and a stated exit.
View sectorPrivate credit
Borrowers and sponsors raising private debt, presented with the security package, coverage and covenant position resolved up front.
View sectorSustainable Wealth Group is not authorised or regulated by the Financial Conduct Authority. Nothing on this page is advice, or an invitation or inducement to engage in investment activity. Capital at risk.